Petronet LNG
Petronet LNG reported a mixed Q3 FY26 with PAT of ₹848 cr (down 2.2% YoY) despite record capacity utilization at Kochi terminal at 29% and Dahej at 94%.
Petronet LNG vs Biocon Q3 FY26
Side-by-side earnings comparison across verified financials, sentiment, risks, and management commentary.
Biocon
Biocon delivered a solid Q3 FY26 with group revenue of ₹4,173 crore (+9% YoY) and EBITDA of ₹951 crore (+21% YoY), driven by strong biosimilar margins (28% vs 21% last year) and generics growth of 24%.
Result Snapshot
Revenue₹11,164 Cr₹4,173 Cr
PAT₹870 Cr₹-52 Cr
EBITDA Margin11%20%
Sentimentbullishbullish
Key Quotes
We are one of the lowest cost operator and our charges are also one of the lowest in the industry.
Q3 FY26 represents an important operational inflection point for Biocon. With major capex now largely behind us and operating leverage beginning to play out, we are progressing from a phase of balance sheet resilience into a cycle of sustainable growth, margin expansion and a cash flow-led value creation.